Omega Seiki Mobility closes INR 100 crore funding across two rounds The electric three-wheeler maker has raised INR 100 crore in two tranches, with its advisor SKG also investing. Investors, valuation and use of proceeds were not disclosed.
What US drug tariffs mean for Indian pharma America is using tariffs to pull drug manufacturing back home, a direct threat to the cheap generics India supplies to the world. Seen through Natco Pharma, what the 2028 tariff clock means for Indian drugmakers, and why it could end up leaving patients paying more.
Yokohama India's Anil Gupta talks about the GEOLANDAR X-CV range Yokohama India's Anil Gupta at the GEOLANDAR X-CV range launch
Omega Seiki Mobility closes INR 100 crore funding across two rounds The electric three-wheeler maker has raised INR 100 crore in two tranches, with its advisor SKG also investing. Investors, valuation and use of proceeds were not disclosed.
SBI General reports Q1 premium growth of 10.9 percent The insurer reported premium income of INR 3,506 crore and profit of INR 426 crore, in what it says are the first general insurance results published under Ind AS.